Invasive fungal infections and COVID-19: a review
Afr. J. Clin. Exp. Microbiol
;
23(1): 14-21, 2022. figures, tables
Article
in English
| AIM
| ID: biblio-1355316
ABSTRACT
Invasive fungal diseases (IFDs) are major causes of morbidity and mortality among hospitalized patients all over the world with a global prevalence of 15%. Since the first case of COVID-19 was reported on February 27, 2020, in Nigeria, it had been discovered across all geopolitical zones in Nigeria. As the medical community confronts the ongoing COVID-19 pandemic, determining whether patients infected with SARS-CoV-2 develop fungal complications, especially invasive aspergillosis, is crucial. This review aimed to highlight the fungal co-infections that might be associated with SARS-CoV-2 infection, and modalities for their diagnosis, prevention, and management, with the view to reducing the high mortality associated with these infections
Full text:
Available
Index:
AIM (Africa)
Main subject:
Invasive Fungal Infections
/
COVID-19
/
Antifungal Agents
Type of study:
Risk factors
Limits:
Female
/
Humans
/
Male
Language:
English
Journal:
Afr. J. Clin. Exp. Microbiol
Year:
2022
Type:
Article
Institution/Affiliation country:
Department of Medical Microbiology and Immunology, Nile University of Nigeria/NG
/
Department of Medical Microbiology and Parasitology, University College Hospital/NG
Similar
MEDLINE
...
LILACS
LIS